Company Description
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.
It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.
The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals.
The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.
The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits.
The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
| Country | United States |
| Founded | 1979 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 48,000 |
| CEO | Jason M. Hollar |
Contact Details
Address: 7000 Cardinal Place Dublin, Ohio 43017 United States | |
| Phone | (614) 757-3033 |
| Website | cardinalhealth.com |
Stock Details
| Ticker Symbol | CAH |
| Exchange | NYSE |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000721371 |
| CUSIP Number | 14149Y108 |
| ISIN Number | US14149Y1082 |
| Employer ID | 31-0958666 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Jason M. Hollar | Chief Executive Officer and Director |
| Aaron E. Alt | Chief Financial Officer |
| Jessica L. Mayer | Chief Legal and Compliance Officer |
| Stephen M. Mason | Chief Executive Officer of Medical Segment |
| Deborah L. Weitzman | Chief Executive Officer of Pharmaceutical Segment |
| Patricia M. English | Senior Vice President |
| Mary C. Scherer | Senior Vice President and Chief Accounting Officer |
| Michelle D. Greene | Executive Vice President, Chief Information Officer and Customer Support Services |
| Matt Sims | Vice President of Investor Relations |
| Ola M. Snow | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2024 | 8-K | Current Report |
| Apr 22, 2024 | 8-K | Current Report |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 20, 2024 | 8-K | Current Report |
| Feb 16, 2024 | 424B5 | Filing |
| Feb 14, 2024 | FWP | Free Writing Prospectus |
| Feb 14, 2024 | 424B5 | Filing |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 1, 2024 | 10-Q | Quarterly Report |
| Feb 1, 2024 | 8-K | Current Report |